| Marian Serra, MD | |
|
1050 E South Temple, Salt Lake City, UT 84102-1507 | |
| (801) 350-4111 | |
| Not Available |
| Full Name | Marian Serra |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Location | 1050 E South Temple, Salt Lake City, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013979129 | NPI | - | NPPES |
| D1884 | Medicaid | UT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207PE0004X | Emergency Medicine - Emergency Medical Services | 322218-1205 (Utah) | Secondary |
| 207P00000X | Emergency Medicine | 322218-1205 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Marian Serra, MD 144 S 500 E, 2nd Floor, Salt Lake City, UT 84102-1907 Ph: () - | Marian Serra, MD 1050 E South Temple, Salt Lake City, UT 84102-1507 Ph: (801) 350-4111 |
News Archive
The American Dental Association (ADA) welcomes Friday's ruling by the U.S. Court of Appeals for the District of Columbia stating that the court cannot force the Food and Drug Administration to tighten restrictions on the use of dental amalgam fillings.
Cancer growth normally follows a lengthy period of development. Over the course of time, genetic mutations often accumulate in cells, leading first to pre-cancerous conditions and ultimately to tumour growth. Using a mathematical model, scientists at the Max Planck Institute for Dynamics and Self-Organization in G-ttingen, University of Pennsylvania and University of California San Francisco, have now shown that spatial tissue structure, such as that found in the colon, slows down the accumulation of genetic mutations, thereby delaying the onset of cancer.
Novelos Therapeutics, Inc., a pharmaceutical company developing novel drugs for treatment and diagnosis of cancer, today announced that it has enrolled the first patient in a U.S. multi-center Phase 1b dose-escalation trial of its cancer-targeted molecular radiotherapeutic compound (131)I-CLR1404 (HOT) in cancer patients with advanced solid tumors.
The Cancer Prevention and Research Institute of Texas has granted $3.7 million to Rice University researchers to fund an innovative cancer diagnostics program.
› Verified 8 days ago
Dr. Benjamin J. Verseman, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 30 N 1900 E # 1c026, Salt Lake City, UT 84132 Phone: 801-581-2417 | |
Dr. Carrie Anderson, DVM Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1021 E 3300 S, Salt Lake City, UT 84106 Phone: 801-942-3951 Fax: 801-942-3951 | |
Lindsey L. Fell, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: Helix: 30 N Mario Capecchi Dr Rm 2s200, Salt Lake City, UT 84112 Phone: 801-581-2121 | |
Jared C Dunn, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 5848 S Fashion Blvd Ste 110, Salt Lake City, UT 84107 Phone: 801-314-4020 Fax: 801-314-4015 | |
Jeffrey Druck, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 50 N Medical Dr, Salt Lake City, UT 84132 Phone: 801-581-2121 | |
Kristen Jahn, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1050 E South Temple, Salt Lake City, UT 84102 Phone: 801-350-4111 |